LU92898I2 - Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31 - Google Patents

Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31 Download PDF

Info

Publication number
LU92898I2
LU92898I2 LU92898C LU92898C LU92898I2 LU 92898 I2 LU92898 I2 LU 92898I2 LU 92898 C LU92898 C LU 92898C LU 92898 C LU92898 C LU 92898C LU 92898 I2 LU92898 I2 LU 92898I2
Authority
LU
Luxembourg
Prior art keywords
gardasil
stereotypes
vlps
hpv
product name
Prior art date
Application number
LU92898C
Other languages
English (en)
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0413510.9A external-priority patent/GB0413510D0/en
Priority claimed from US11/114,301 external-priority patent/US20050287161A1/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of LU92898I2 publication Critical patent/LU92898I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
LU92898C 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31 LU92898I2 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0413510.9A GB0413510D0 (en) 2004-06-16 2004-06-16 Vaccine
US11/114,301 US20050287161A1 (en) 2002-12-20 2005-04-26 Vaccine
PCT/EP2005/006461 WO2005123125A1 (fr) 2004-06-16 2005-06-14 Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52

Publications (1)

Publication Number Publication Date
LU92898I2 true LU92898I2 (fr) 2016-03-08

Family

ID=35160037

Family Applications (3)

Application Number Title Priority Date Filing Date
LU92899C LU92899I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
LU92898C LU92898I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
LU92900C LU92900I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LU92899C LU92899I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU92900C LU92900I2 (fr) 2004-06-16 2015-12-08 Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31

Country Status (18)

Country Link
EP (1) EP1758609B1 (fr)
JP (1) JP2008502633A (fr)
KR (1) KR20070029254A (fr)
AR (1) AR049354A1 (fr)
AU (1) AU2005253723B2 (fr)
BR (1) BRPI0512042B8 (fr)
CA (1) CA2566620C (fr)
FR (2) FR15C0082I2 (fr)
IL (1) IL179138A0 (fr)
LU (3) LU92899I2 (fr)
MA (1) MA28692B1 (fr)
MX (1) MXPA06014515A (fr)
NO (1) NO20070195L (fr)
PE (1) PE20060434A1 (fr)
PL (1) PL1758609T3 (fr)
RU (1) RU2420313C2 (fr)
SG (1) SG153837A1 (fr)
WO (1) WO2005123125A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080005583A (ko) * 2005-04-26 2008-01-14 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
SI2318042T1 (sl) * 2008-07-31 2014-12-31 Glaxosmithkline Biologicals S.A. Cepivo proti HPV
WO2010147268A1 (fr) * 2009-06-19 2010-12-23 아이진 주식회사 Vaccin contre le cancer du col de l'uterus
JP5964298B2 (ja) * 2010-07-15 2016-08-03 ブリティッシュ コロンビア キャンサー エージェンシー ブランチ ヒトパピローマウイルスｅ７抗原組成物およびその使用
SG11201501623PA (en) 2012-10-30 2015-05-28 Redvax Gmbh Recombinant particle based vaccines against human cytomegalovirus infection
EP3209676A4 (fr) * 2014-10-24 2018-03-28 Hpvvax, Llc Traitement du cancer et de lésions cutanées
CN107188966B (zh) 2016-03-15 2020-03-31 中国医学科学院基础医学研究所 一种乳头瘤病毒嵌合蛋白及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921147D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
GB0110431D0 (en) * 2001-04-27 2001-06-20 Glaxosmithkline Biolog Sa Novel compounds
GB0206359D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
GB0206360D0 (en) * 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
ATE503492T1 (de) * 2002-12-20 2011-04-15 Glaxosmithkline Biolog Sa Verwendung von hpv16 und hpv18 vlps als vakzine gegen eine oder mehrere onkogene hpv des typus 31,33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68

Also Published As

Publication number Publication date
RU2006143804A (ru) 2008-08-20
FR15C0082I2 (fr) 2016-10-28
AU2005253723B2 (en) 2011-01-20
JP2008502633A (ja) 2008-01-31
FR15C0084I2 (fr) 2016-10-28
FR15C0082I1 (fr) 2016-01-08
CA2566620C (fr) 2014-03-11
EP1758609B1 (fr) 2012-10-03
MXPA06014515A (es) 2007-03-23
KR20070029254A (ko) 2007-03-13
BRPI0512042B8 (pt) 2021-05-25
AU2005253723A1 (en) 2005-12-29
NO20070195L (no) 2007-01-15
PL1758609T3 (pl) 2013-02-28
AR049354A1 (es) 2006-07-19
LU92899I2 (fr) 2016-03-08
IL179138A0 (en) 2007-03-08
EP1758609A1 (fr) 2007-03-07
LU92900I2 (fr) 2016-03-08
RU2420313C2 (ru) 2011-06-10
BRPI0512042A (pt) 2008-02-06
FR15C0084I1 (fr) 2016-01-08
PE20060434A1 (es) 2006-06-08
MA28692B1 (fr) 2007-06-01
WO2005123125A1 (fr) 2005-12-29
CA2566620A1 (fr) 2005-12-29
SG153837A1 (en) 2009-07-29
BRPI0512042B1 (pt) 2019-01-22

Similar Documents

Publication Publication Date Title
LU92899I2 (fr) Gardasil-9/vaccination contre les stéréotypes 16,18 et 31 nom de produit: hpv l1 vlps 16+18+31
NO2017005I1 (no) Human pappilomavirus vaksine [type 6, 11, 16, 18, 31, 33, 45, 52, 58]
EP2262883A4 (fr) Préparations de nettoyage, d'assainissement et de stérilisation
LU92902I2 (fr) Gardasil-9/nom du produit: protéine hpv 45 l1
TWI365866B (en) Amide derivatives, process for preparation thereof and use thereof as insecticide
LU92901I2 (fr) Gardasil-9/ nom du produit: protéine hpv58l1
EP2046352A4 (fr) Produit de lait fermenté et son utilisation
IL182470A0 (en) Semi-soft c-class immunostimulatory oligonucleotides
PL2094849T3 (pl) Długotrwała zmiana przebiegu choroby z zastosowaniem oligonukleotydów immunostymulujących
EP2147926A4 (fr) Protéines 18 l1 de type papillomavirus humain tronque
ITTO20040434A1 (it) Confezione multipla di buste contenenti prodotti ad uso medicale.
FR2877842B1 (fr) Produit aerosol anti-transpirant
EP1933989A4 (fr) Produit parfume, distributeur et ensemble distributeur
ATE405326T1 (de) Kosmetiktuchprodukt
GB2411205B (en) Disposable products
GB0506912D0 (en) Biological products
ITTO20060175U1 (it) Espositore, particolarmente adatto per prodotti dolciari.
FI20031065A0 (fi) Hyönteissuoja-aine, menetelmä sen valmistamiseksi ja sen käyttö
FR2859212B1 (fr) Fluxant, solumere et composition bitumineuse en contenant, preparation et application de ces produits
PL1889595T3 (pl) Wyrób do oczyszczania i/lub pielęgnacji skóry oraz sposób wytwarzania wspomnianego wyrobu
ITRM20040509A1 (it) Procedimento di ingobbio per caramiche e prodotto derivato.
AU2005902986A0 (en) Single-use container, closure and serving implement
ITBG20040037A1 (it) Prodotto dolciario
EP1935277A4 (fr) Systeme de garantie d'hygiene pour peignes a usage unique
ITMO20050281A1 (it) Prodotto dolciario